Accelerating CAR T cell manufacturing with an automated next-day process
M. Ahmadi, N. Putnam, D. Hayoun, M. Dotson, J. Padilla, N. Fatima, G. Nonterah, X. de Mollerat du Jeu, Y. Ji
This study introduces an automated 24-hour CAR T cell manufacturing process that increases naive/stem-cell like T cells and cytotoxic activity, potentially improving therapy efficacy and patient access.
bioRxiv · Jun 4, 2024Bioengineering